U.S. markets closed

Syneos Health, Inc. (SYNH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
86.25+0.46 (+0.54%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Bollinger Bands

Bollinger Bands

Previous Close85.79
Bid86.27 x 1200
Ask86.30 x 1400
Day's Range85.08 - 86.88
52 Week Range48.01 - 86.88
Avg. Volume957,680
Market Cap8.989B
Beta (5Y Monthly)1.82
PE Ratio (TTM)47.13
EPS (TTM)1.83
Earnings DateApr 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est86.73
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
7% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is SYNH Stock A Buy or Sell?
    Insider Monkey

    Is SYNH Stock A Buy or Sell?

    The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]

  • Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021

    Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021

    MORRISVILLE, N.C., April 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings call at 8:00 a.m. ET. Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on April 29, 2021. About Syneos HealthSyneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 25,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast. Investor Relations Contact:Ronnie SpeightSenior Vice President, Investor Relations+1 919 745 2745Investor.Relations@syneoshealth.com Press/Media Contact:Gary GatyasExecutive Director, External Communications+1 908 763 3428gary.gatyas@syneoshealth.com